Physiological processes

36 trials 8 recruiting

Filter these 36 trials by phase, country and sponsor.

Open in Search →

Oxytocine and migraine Pending

2023-504690-21-00 This is a study in healthy volunteers. We will study t 3
Assessing Oxytocin's Role in Mitigating Psychosocial Stress in Breast Cancer Survivors Pending

2024-519383-40-00 breast cancer 5
Magnetic Resonance Assessment of Variations in Effects of anaesthesia on renaL perfusion in children Pending

2025-520627-25-00 Post-operative Acute Kidney Injury 6
Study on the effect of 6qc-ICG on the skin of healthy volunteers and in patients with breast cancer during surgeries. Pending

2025-523166-24-00 Breast cancer 7
COMPASS - COpenhagen MenoPAuSe Study Pending

2025-522558-37-00 Menopause 4
Long-term clinical trial on tolerability, toxicity, pharmacokinetics and molecular mechanisms of action of EPI-EE Pending

2025-520751-83-00 Eosinophilic Esophagitis as a archetype of chronic infl 3
The effect of CBD on sleep quality following late evening exercise Recruiting

2024-518609-17-00 healthy individuals 4 2026-03-19
The effect of transdermal 17-β-estradiol/progesterone supplementation on glucose regulation in peri- and postmenopausal women with type 1 an… Recruiting

2025-523214-83-00 Diabetes Mellitus 6 2026-02-09
Esmolol versus Sufentanil on the quality of recovery after laparoscopic cholecystectomy during anesthesia with oro-tracheal intubation on am… Recruiting

2024-520282-31-00 Laparoscopic Cholecystectomy 6 2025-10-23
The use of sildenafil in patients with univentricular heart after Fontan operation - a pilot SINFON-POL study. Recruiting

2023-503913-31-01 Patients with functionally single ventricle (FSV - func 5 2025-06-27
Clear-Brain: stimulating amyloid clearance in cerebral amyloid angiopathy Recruiting

2023-506128-10-00 Cerebral amyloid angiopathy 4 2025-03-27
Use of Levosimendan as treatment of aneurysmal Hemorrhage Recruiting

2024-514242-36-00 subarachnoid hemorrhages of aneurysmal origin (HSAa) 4 2024-11-04
STUDY OF OP-1250 ADMINSTERED AS MONOTHERAPY AND COMPARED TO STANDARD OF CARE FOR THE TREATMENT OF ER+, HER2– ADVANCED OR METASTATIC BREAST C… Recruiting

2023-505871-63-00 ER+, HER2- metastatic breast cancer following endocrine 5 2024-04-08
InvestiGating the rOle of Growth Hormone in hepatic lipid metabolism in humans Recruiting

2024-518214-11-01 acromegaly 4 2022-01-01
Affective effects of pre-surgery opioids (AFFECT2): a randomized, doubleblind placebo-controlled trial Ended

2024-518308-37-00 Health status ASA1 or ASA2 as categorised by a medical 6 2022-12-13
Towards a treatment for accelerated maturation in girls testing spiomet. Ended

2024-518675-55-00 Girls with advanced puberty and accelerated bone matura 4 2022-12-02
Capivasertib + Abiraterone as Treatment for Patients with Metastatic Hormone-sensitive Prostate Cancer Characterised by PTEN deficiency (CAP… Ended

2023-504998-20-00 Metastatic Hormone-sensitive Prostate Cancer Characteri 5 2020-09-18
Extension of a clinical trial to assess the safety of a study drug called "CORT125134" in the treatment of Cushing Syndrome Ended

2024-514079-17-00 Endogenous Cushing Syndrome 10 2020-05-28
Mechanisms of Action of Paradoxical Responses to Zolpidem: A Multimodal Study Halted

2023-507404-31-03 Patients with acquired partial/total vision impairments 4 2025-02-11
Evaluation of the bioavailability of two transdermal gel preparations containing 0.1% w/w estradiol under fasting conditions: Estradiol/INTE… Ended

2024-517969-16-00 No therapeutic indication in the current trial with hea 3 2025-03-12
Neurogenic inflammation upon AITC-induced TRPA1 activation Ended

2025-520494-40-00 Not applicable; this trial investigates a physiological 3 2025-03-04
BATOLISA Ended

2024-513529-21-00 Lipedema 6 2025-01-24
Evaluation of irritation potential of topical formulations on intact skin Ended

2024-511826-29-00 Dermal tolerability test: Testing for non-specific, loc 3 2024-06-20
Assessment of narrowing of blood vessels after single application of two clascoterone formulations (cream and solution) onto the skin in com… Ended

2023-507241-28-00 Test of vasocontriction properties for classification o 3 2024-02-26